About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? [email protected]

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Sparing in Neuromuscular Blockade in COVID 19 ICU

NCT04459533·1 site·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Hospices Civils de Lyon

Age

18–any

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

PCR-proven SARS-CoV-2 infection
Use of VM (mechanical ventilation)
Use of NMB agents for at least 48 hours

You may not be if

Pregnancy
extracorporeal membrane oxygenation (ECMO)

The record

StatusCompleted

PhaseNo phase

Taking part250

StartedJun 2020

UpdatedJul 7, 2020

Conditions

Neuromuscular Blockade Human Characteristics Complication of Medical Care Intensive Care Unit Acquired Weakness

Where1

Department of Anesthesiology and Intensive Care Medicine, Hôpital de la Croix Rousse, Hospices Civils de Lyon
Lyon, France

Clareo Health | Sparing in Neuromuscular Blockade in COVID 19 ICU